Matthias Werner Hentze, MD is a German scientist. Currently, he is the Director of the European Molecular Biology Laboratory (EMBL) and Professor of Molecular Medicine at Heidelberg University. Matthias Hentze studied medicine in the UK at the medical schools at the University of Southampton, University of Oxford, University of Glasgow and University of Cambridge, and in Germany at the Westfälische Wilhelms-Universität, Münster from which he qualified in 1984.
After a short phase of clinical work and supported by a fellowship awarded by the Deutsche Forschungsgemeinschaft (German Research Council), Hentze became a postdoctoral fellow in Dr. Richard Klausner’s laboratory at the National Institutes of Health (NIH), Bethesda, Maryland, United States in 1985. In 1989, he joined the European Molecular Biology Laboratory in Heidelberg as an independent group leader. He served as Dean of the EMBL International Ph.D. Programme from 1996 until 2005, when he became Associate Director of the EMBL and Professor for Molecular Medicine at the University of Heidelberg. Together with Prof. Andreas Kulozik of the Medical Faculty of Heidelberg University, Hentze co-founded the Molecular Medicine Partnership Unit (MMPU) in 2002 and serves as its Co-Director. He is also co-founder of Anadys Pharmaceuticals, San Diego, California.
Since 2013, Matthias Hentze is the Director of EMBL, advising and supporting EMBL's Director General, Prof. Iain Mattaj.